Landos Biopharma, Inc. — Form D
Landos Biopharma, Inc. of BLACKSBURG, VA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-23. The offering totals $60.3M, of which $60.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-23
- Form: D
- Accession: 0001785345-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.3M
- Amount sold: $60.3M
- Investors: 10
- Date of first sale: 2019-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-347303
Issuer
- Name: Landos Biopharma, Inc.
- CIK: 0001785345
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1800 KRAFT DRIVE, SUITE 216, BLACKSBURG, VA, 24060
- Phone: 540-818-2844
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Josep Bassaganya-Riera | Director | Blacksburg, VA |
| Christopher Garabedian | Director | Waltham, MA |
| Josep Bassaganya-Riera | Executive Officer | Blacksburg, VA |
More